Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 638645, 10 pages
http://dx.doi.org/10.1155/2015/638645
Review Article

Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention

1Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
2Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
3Colorado State University, Cancer Prevention Laboratory, Collins, CO 80523, USA
4The Irma H. Russo MD Breast Cancer Research Laboratory, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA
5Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, 14784-400 Barretos, SP, Brazil
6Molecular Oncology Research Center, Barretos Cancer Hospital, 14784-400 Barretos, SP, Brazil

Received 25 September 2014; Accepted 23 December 2014

Academic Editor: Kyu Lim

Copyright © 2015 Andrea Manni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Fisher, J. P. Costantino, D. L. Wickerham et al., “Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study,” Journal of the National Cancer Institute, vol. 90, no. 18, pp. 1371–1388, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. V. G. Vogel, J. P. Costantino, D. L. Wickerham et al., “Update of the national surgical adjuvant breast and bowel project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: preventing breast cancer,” Cancer Prevention Research, vol. 3, no. 6, pp. 696–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Fagerlin, A. J. Dillard, D. M. Smith et al., “Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid,” Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 681–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Ropka, J. Keim, and J. T. Philbrick, “Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis,” Journal of Clinical Oncology, vol. 28, no. 18, pp. 3090–3095, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Waters, K. A. Cronin, B. I. Graubard, P. K. Han, and A. N. Freedman, “Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 2, pp. 443–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Visvanathan, R. T. Chlebowski, P. Hurley et al., “American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction,” Journal of Clinical Oncology, vol. 27, no. 19, pp. 3235–3258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. E. Goss, J. N. Ingle, J. E. Ales-Martinez et al., “Exemestane for breast-cancer prevention in postmenopausal women,” The New England Journal of Medicine, vol. 364, pp. 2381–2391, 2011. View at Publisher · View at Google Scholar
  8. K. K. Carroll and L. M. Braden, “Dietary fat and mammary carcinogenesis,” Nutrition and Cancer, vol. 6, no. 4, pp. 254–259, 1984. View at Google Scholar · View at Scopus
  9. D. Engeset, E. Alsaker, E. Lund et al., “Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC),” International Journal of Cancer, vol. 119, no. 1, pp. 175–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. MacLean, S. J. Newberry, W. A. Mojica et al., “Effects of omega-3 fatty acids on cancer risk: a systematic review,” Journal of the American Medical Association, vol. 295, no. 4, pp. 403–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-S. Zheng, X.-J. Hu, Y.-M. Zhao, J. Yang, and D. Li, “Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies,” British Medical Journal, vol. 346, Article ID f3706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Manni, H. Xu, S. Washington et al., “The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-Methyl-N-Nitrosourea-Induced rat mammary carcinogenesis,” Cancer Prevention Research, vol. 3, no. 3, pp. 322–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Manni, J. P. Richie Jr., H. Xu et al., “Influence of omega-3 fatty acids on Tamoxifen-induced suppression of rat mammary carcinogenesis,” International Journal of Cancer, vol. 134, no. 7, pp. 1549–1557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Manni, J. P. Richie Jr., H. Xu et al., “Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea- induced rat mammary carcinogenesis,” International Journal of Oncology, vol. 39, no. 5, pp. 1153–1164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. D. Yee, D. C. Young, T. J. Rosol, A. M. VanBuskirk, and S. K. Clinton, “Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARγ ligand rosiglitazone,” The Journal of Nutrition, vol. 135, no. 5, pp. 983–988, 2005. View at Google Scholar · View at Scopus
  16. A. Manni, H. Xu, S. Washington et al., “The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice,” Hormones and Cancer, vol. 2, no. 4, pp. 249–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Signori, K. El-Bayoumy, J. Russo et al., “Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations,” Cancer Research, vol. 71, no. 19, pp. 6091–6096, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Zhu, W. Jiang, J. N. McGinley et al., “Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat,” Cancer Prevention Research (Philadelphia, Pa), vol. 4, no. 10, pp. 1675–1685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Cuzick, J. Warwick, E. Pinney et al., “Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study,” Journal of the National Cancer Institute, vol. 103, no. 9, pp. 744–752, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kim, W. Han, H.-G. Moon et al., “Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer,” Breast Cancer Research, vol. 14, article R102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Jiang, Z. Zhu, J. N. McGinley, K. El Bayoumy, A. Manni, and H. J. Thompson, “Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids,” Cancer Research, vol. 72, no. 15, pp. 3795–3806, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Bonofiglio, S. Gabriele, S. Aquila et al., “Estrogen receptor α binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor γ signaling in breast cancer cells,” Clinical Cancer Research, vol. 11, no. 17, pp. 6139–6147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Wang and M. W. Kilgore, “Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells,” Molecular and Cellular Endocrinology, vol. 194, no. 1-2, pp. 123–133, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, “Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies,” Nutrition and Cancer, vol. 61, no. 3, pp. 287–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. T. Bidinotto, R. L. de Cicco, J. E. Vanegas et al., “Fish oil alters tamoxifen-modulated expression of mRNAs that encode genes related to differentiation, proliferation, metastasis, and immune response in rat mammary tumors,” Nutrition and Cancer, vol. 64, no. 7, pp. 991–999, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. G. Skibinski, H. J. Thompson, A. Das et al., “Proteomic changes induced by effective chemopreventive ratios of n-3:n-6 fatty acids and tamoxifen against MNU-induced mammary cancer in the rat,” Cancer Prevention Research, vol. 6, no. 9, pp. 979–988, 2013. View at Google Scholar · View at Scopus
  27. H. L. Asch, K. Head, Y. Dong et al., “Widespread loss of gelsolin in breast cancers of humans, mice, and rats,” Cancer Research, vol. 56, no. 21, pp. 4841–4845, 1996. View at Google Scholar · View at Scopus
  28. J. Welsh, “Vitamin D metabolism in mammary gland and breast cancer,” Molecular and Cellular Endocrinology, vol. 347, no. 1-2, pp. 55–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Hermeking, C. Lengauer, K. Polyak et al., “14-3-3σ is a p53-regulated inhibitor of G2/M progression,” Molecular Cell, vol. 1, no. 1, pp. 3–11, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Zeng, M. Hincapie, S. J. Pitteri et al., “A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome,” Analytical Chemistry, vol. 83, no. 12, pp. 4845–4854, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Tian, Y.-Z. Cui, G.-H. Song et al., “Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients,” BMC Cancer, vol. 8, article 241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Kreunin, J. Zhao, C. Rosser, V. Urquidi, D. M. Lubman, and S. Goodison, “Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling,” Journal of Proteome Research, vol. 6, no. 7, pp. 2631–2639, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. I. Goufman, S. A. Moshkovskii, O. V. Tikhonova et al., “Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions,” Biochemistry (Moscow), vol. 71, no. 4, pp. 354–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. I. van den Broek, R. W. Sparidans, A. W. J. van Winden et al., “The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients,” Proteomics—Clinical Applications, vol. 4, no. 12, pp. 931–939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. W. J. Opstal-van Winden, E. J. M. Krop, M. H. Kåredal et al., “Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study,” BMC Cancer, vol. 11, article 381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Signori, C. Dubrock, J. P. Richie et al., “Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: Interim feasibility and biomarkers analysis from a clinical trial,” European Journal of Clinical Nutrition, vol. 66, no. 8, pp. 878–884, 2012. View at Publisher · View at Google Scholar · View at Scopus